MQ:NASDAQMarqeta, Inc. analysis
Data as of Jun 2, 2026 - not real-time
- Latest price
- $4.25
- Risk: medium
- 6/10Medium risk
Summary
Marqeta posted solid double‑digit revenue growth and a modest GAAP profit beat, underscoring the resilience of its open‑API card platform. The stock trades well below its discounted cash‑flow estimate, suggesting a sizable upside, yet its price‑to‑earnings multiple dwarfs the industry average, reflecting lingering concerns about profitability.
The technical picture is mixed: the 20‑day SMA sits just above the current price, the 200‑day SMA remains higher, indicating a longer‑term bearish bias, while the MACD histogram has flipped positive and the RSI hovers in neutral territory. Volume is on the rise, and the market sentiment index is in “Extreme Greed,” hinting that speculative enthusiasm may be supporting the price despite fundamental headwinds.
The technical picture is mixed: the 20‑day SMA sits just above the current price, the 200‑day SMA remains higher, indicating a longer‑term bearish bias, while the MACD histogram has flipped positive and the RSI hovers in neutral territory. Volume is on the rise, and the market sentiment index is in “Extreme Greed,” hinting that speculative enthusiasm may be supporting the price despite fundamental headwinds.
Market outlook
Short term
< 1 yearNeutral
Model confidence6/106 out of 10
Key factors
- Price near recent support with limited downside cushion
- Bullish MACD histogram offset by overall bearish trend
- Elevated volatility and high market greed index
Medium term
1–3 yearsPositive
Model confidence7/107 out of 10
Key factors
- Consistent revenue expansion and entry into new European markets
- DCF‑derived fair value indicating ~22% upside
- Strong cash position relative to modest debt
Long term
> 3 yearsNeutral
Model confidence5/105 out of 10
Key factors
- Long‑term tailwinds in digital payments and card‑issuing APIs
- Thin profit margins and high P/E relative to peers
- Potential for improved earnings as scale and product mix evolve
Key metrics
Financial health
Revenue Growth19.20%
Profit Margin0.33%
P/E Ratio425.0
ROE0.25%
ROA-0.99%
Debt/Equity0.99
P/B Ratio2.4
Op. Cash Flow$149.3M
Free Cash Flow$116.2M
Industry P/E43.3
Technical analysis
TrendBearish
RSI57.0
Support$3.72
Resistance$4.64
MA 20$4.03
MA 50$4.13
MA 200$4.66
MACDBullish
VolumeIncreasing
Fear & Greed Index92.93
Valuation
Fair Value$9.64
Target Price$5.19
Upside/Downside22.14%
GradeUndervalued
TypeGrowth
Risk assessment
Beta0.82
Volatility44.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar tickers
DNMX
Dynamix Corporation III
stockZENA
ZenaTech, Inc.
stockZBIO
Zenas BioPharma, Inc.
stockYELP
Yelp Inc.
stockABCL
AbCellera Biologics Inc.
stockWTFCN
Wintrust Financial Corporation - Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 7.875% Fixed-Rate Reset Non-Cumulative Perpetual Prefer
stockThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.